COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 1080: Articles 10791-10800  | Next

Antibody binding and ACE2 binding inhibition is significantly reduced for the Omicron variant compared to all other variants of concern
Junker, D., Becker, M., Wagner, T., Kaiser, P. D., Maier, S., Grimm, T. M., Griesbaum, J., Marsall, P., Gruber, J., Traenkle, B., Heinzel, C., Pinilla, Y. T., Held, J., Fendel, R., Kreidenweiss, A., Nelde, A., Maringer, Y., Schroeder, S., Walz, J. S., Althaus, K., Uzun, G., Mikus, M., Bakchoul, T., Schenke-Layland, K., Bunk, S., Haeberle, H., Bitzer, M., Goepel, S., Renk, H., Remppis, J., Engel, C., Franz, A. R., Harries, M., Kessel, B., Strengert, M., Krause, G., Zeck, A., Rothbauer, U., Dulovic, A., Schneiderhan-Marra, N.
10.1101/2021.12.30.21267519 — Posted: 2022-01-01
Predicting the impact of COVID-19 vaccination campaigns - a flexible age-dependent, spatially-stratified predictive model, accounting for multiple viral variants and vaccines
Schneider, K. A., Tsoungui Obama, H. C. J., Adil Mahmoud Yousif, N., Ngougoue Ngougoue, P. M.
10.1101/2021.12.29.21268526 — Posted: 2022-01-01
Global Perspective of COVID-19 Vaccine Nationalism
Basak, P., ABIR, T., Mamun, A. A., Zainol, N. R., Khanam, M., Haque, M. R., Milton, A. H., Agho, K. E.
10.1101/2021.12.31.21268580 — Posted: 2022-01-01
Effectiveness of COVID-19 vaccines against Omicron or Delta infection
Buchan, S. A., Chung, H., Brown, K. A., Austin, P. C., Fell, D. B., Gubbay, J., Nasreen, S., Schwartz, K. L., Sundaram, M. E., Tadrous, M., Wilson, K., Wilson, S. E., Kwong, J.
10.1101/2021.12.30.21268565 — Posted: 2022-01-01 Discussion: Onsite
Humoral immune responses against SARS-CoV-2 variants including omicron in solid organ transplant recipients after three doses of a COVID-19 mRNA vaccine
Saharia, K. K., Husson, J. S., Niederhaus, S. V., Iraguha, T., Avila, S. V., Yoo, Y. J., Hardy, N. M., Fan, X., Omili, D., Crane, A., Carrier, A., Xie, W. Y., Vander Mause, E., Hankey, K., Bauman, S., Lesho, P., Mannuel, H. D., Ahuja, A., Mathew, M., Avruch, J., Baddley, J., Goloubeva, O., Shetty, K., Dahiya, S., Rapoport, A. P., Luetkens, T., Atanackovic, D.
10.1101/2021.12.29.21268529 — Posted: 2022-01-01
Early signals of significantly increased vaccine breakthrough, decreased hospitalization rates, and less severe disease in patients with COVID-19 caused by the Omicron variant of SARS-CoV-2 in Houston, Texas
Christensen, P. A., Olsen, R. J., Long, S. W., Snehal, R., Davis, J. J., Ojeda Saavedra, M., Reppond, K., Shyer, M. N., Cambric, J., Gadd, R., Thakur, R. M., Batajoo, A., Mangham, R., Pena, S., Trinh, T., Kinskey, J. C., Williams, G., Olson, R., Golihar, J., Musser, J. M.
10.1101/2021.12.30.21268560 — Posted: 2022-01-01 Discussion: Onsite
A Web-based Spatial Decision Support System of Wastewater Surveillance for COVID-19 Monitoring: A Case Study of a University Campus
Tang, W., Chen, T., Slocum, Z., Lan, Y., Delmelle, E., Chen, D., Mittal, N., Rice-Boayue, J., Shuka, T., Lin, S., Akella, S., Schlueter, J., Munir, M., Gibas, C. J.
10.1101/2021.12.29.21268516 — Posted: 2022-01-01
Sample Size Calculations for Variant Surveillance in the Presence of Biological and Systematic Biases
Wohl, S., Lee, E. C., DiPrete, B. L., Lessler, J.
10.1101/2021.12.30.21268453 — Posted: 2022-01-01
Inferring effects of mutations on SARS-CoV-2 transmission from genomic surveillance data
Lee, B., Sohail, M. S., Finney, E., Ahmed, S. F., Quadeer, A. A., McKay, M. R., Barton, J. P.
10.1101/2021.12.31.21268591 — Posted: 2022-01-01
Increased Risk of Poor Clinical Outcome in COVID-19 Patients with Diabetes Mellitus and in-hospital Mortality Predictors: A Retrospective Cohort from a Tertiary Hospital in Indonesia
Mokoagow, M. I., Saksono Harbuwono, D., Kshanti, I. A., Rumende, C. M., Subekti, I., Harimurti, K., Lie, K. C., Shatri, H.
10.1101/2021.12.30.21266217 — Posted: 2022-01-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).